Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
navigation Sample preparation
navigation Cell separation
navigation Cell analysis
navigation Cell culture
navigation Molecular applications
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
MACS Cytokines
MACS Cell Analysis
Tissue Dissociation
Neuroscience
Genomic Services
Miltenyi Biotec
Stemgent® Purified Mouse Anti-Human CD29 Antibody
Description
Stemgent® Purified Mouse anti-Human CD29 Antibody was screened on normal human mesenchymal stem cells (MSC) by immunocytochemistry (ICC) and flow cytometry (FC) and selected as the best CD29 antibody for characterizing and/or isolating human mesenchymal stem cells. The CD29 molecule is a 130 kDa single chain type I glycoprotein (also known as integrin β1 chain subunit) that is expressed in a heterodimeric complex with one of six distinct α subunits, comprising the very late activation antigen (VLA) subfamily of adhesion receptors. It is one of the essential surface molecules expressed on human MSC from bone marrow and other sources1-3. The β1 subunit is also broadly expressed on lymphocytes and monocytes, weakly expressed on granulocytes, and not expressed on erythrocytes. These receptors are involved in a variety of cell-cell and cell-matrix interactions4-6.
Clone Isotype
TS2/16Mouse IgG1κ
Specifications and technical documents
Specification SheetsMaterial Safety Data SheetsProtocols
 
Figure 1
Immunocytochemistry Analysis of Human MSCs.
Figure 2
Flow Cytometry Analysis of Human MSCs.
Miltenyi Biotec
Search this website
Services
Customer login
Contact
Newsletter
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
Stemgent Purified Mouse Anti-Human CD29 Antibody
- 50 μg
- Stemgent Catalog #09-0025
130-095-637
Qty.:
 

References
1. Pittenger, M.F. et al. (1999) Science 284: 143–147.
2. Campagnoli et al. (2001) Blood 98: 2396–2402.
3. Lee et al. (2004) Cell Physiol Biochem 14: 311–324.
4. Cervella et al. (1993) J Biol Chem 268: 5148–5155.
5. Hemler and Lobb (1995) Curr Opin Hematol 2: 61–67.
6. Brakebusch and Fassler (2005) Cancer Metastasis Rev 24: 403–411.
MACS Stem Cell newsletter
Stay current with important developments in stem cell research by subscribing to Stem Cell Updates.
 
 
 
 
 
 
 
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website